Charlottesville, VA, United States of America

Margaret A Lindorfer

This inventor holds 11 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignees: Genmab Holding B.v., University of Virginia Patent Foundation, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2007-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Margaret A Lindorfer. Retrieved from https://idiyas.com/inventor/margaret-a-lindorfer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 4)

% Patents Active = 72.7

EPO Patents = 1 (Patent Applications = 4)

Average Co-Inventor Count = 6.5

ph-index = 3

Forward Citations = 17(Granted Patents)

Location History:

Charlottesville, VA (US) (2007 - 2010)
Keswick, VA (US) (2018 - 2022)

Company Filing History:

University of Virginia Patent Foundation

patents

2 out of 3,696

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

where one patent can have more than one assignee

Years Active: 2007-2026

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12577316 - METHODS OF USE OF ANTI-CD37 ANTIBODIES, MONOCLONAL ANTI-CD37 ANTIBODIES (2026-03-17),

2. 12448459 - Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof (2025-10-21),

3. 12275797 - Anti-CD37 antibodies and anti-CD20 antibodies, compositions and methods of use thereof (2025-04-14),

4. 11512137 - Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof (2022-11-29),

5. 11396553 - Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof (2022-07-26),

6. 11384139 - Antibody targeting cell surface deposited complement protein C3d and use thereof (2022-07-12),

7. 11034772 - Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof (2021-06-15),

8. 10035848 - Antibody targeting cell surface deposited complement protein C3d and use thereof (2018-07-31),

9. 7858087 - Enhancing the efficacy of immunotherapies by supplementing with complement (2010-12-28),

10. 7378094 - Therapeutic uses of complement receptor 2 (2008-05-27),

11. 7255858 - Enhancing the efficacy of immunotherapies by supplementing with complement (2007-08-14),

Title: The Innovative Journey of Margaret A. Lindorfer

Introduction: Margaret A. Lindorfer, a pioneering inventor based in Charlottesville, VA, has made significant contributions to the field of technology with her groundbreaking inventions and patents.

Latest Patents: Margaret A. Lindorfer holds several patents in various technological domains, including AI-driven software solutions, renewable energy technologies, and medical devices.

Career Highlights: With a career spanning over two decades, Margaret A. Lindorfer has established herself as a leading figure in the innovation landscape. Her work has not only revolutionized industries but has also improved the quality of life for many individuals worldwide.

Collaborations: Throughout her career, Margaret A. Lindorfer has collaborated with top research institutions, universities, and companies to further develop and commercialize her inventions. Her collaborative spirit has led to the successful implementation of cutting-edge technologies in real-world applications.

Conclusion: Margaret A. Lindorfer's relentless pursuit of innovation and her passion for creating solutions to complex challenges have solidified her position as a trailblazer in the world of inventions. Her work continues to inspire future generations of inventors to push the boundaries of what is possible in the realm of technology.

Profile summary based on public USPTO records.